Reporter Jan 28 2022
Accelerating podocyte production
Feb. 1, 2022—A new method developed by Vanderbilt researchers to generate kidney cells from stem cells offers a faster and less expensive way to make these valuable tools for studying kidney diseases.
Impact of digital health interventions
Jan. 31, 2022—Vanderbilt researchers test and recommend statistical approaches to study the association between engagement with digital health interventions and clinical outcomes.
White matter and psychosis
Jan. 27, 2022—The microstructure of white matter in the brain could be an important risk marker for psychosis, Vanderbilt researchers have discovered.
Relating to transplant patients comes naturally for Sizemore
Jan. 27, 2022—When Vanderbilt's Kanisha Sizemore, CPhT, helps transplant patients with their medications, she knows what they’re going through.
Initiative shares ECMO expertise with Ballad Health
Jan. 27, 2022—Vanderbilt University Medical Center recently hosted representatives of Ballad Health, a regional health system serving East Tennessee and Southwest Virginia, to train its team to provide a life-saving medical program called ECMO.
Internal medicine residency handbook keeps growing
Jan. 27, 2022—The Vanderbilt internal medicine residency handbook has long been a resource that is easy, enjoyable and helpful for residents to use in clinical practice.
Children’s Hospital program brought flu vaccines to underserved areas
Jan. 27, 2022—by Christina Echegaray Before the current rise in flu cases in Middle Tennessee, a group of doctors and nurses at Monroe Carell Jr. Children’s Hospital at Vanderbilt set out in the fall to protect children from flu before it ever arrived. The team, led by pediatrician Elizabeth Williams, MD, MPH, dubbed its project “The Mobile...
New fund supports appendiceal cancer research
Jan. 27, 2022— by Tom Wilemon The newly established Dalton Family Foundation Appendix Cancer Research Fund will support investigations by the Division of Epidemiology at Vanderbilt University Medical Center to better understand this rare malignancy. An initial grant from the Dalton Family Foundation will fund the work of Andreana Holowatyj, PhD, MSCI, assistant professor of Medicine, and...
Impaired neutrophils in autoimmunity
Jan. 27, 2022—Vanderbilt researchers help answer the question of why patients with autoimmune diseases like lupus are more susceptible to bacterial infections: their neutrophils have impaired antibacterial activity.
Tennessee Poison Center director Seger retires
Jan. 27, 2022— by Kylie Avery Donna Seger, MD, retired in December 2021 after working for 33 years at Vanderbilt University Medical Center and the Tennessee Poison Center (TPC). Seger began her career at VUMC in 1988 in the Department of Emergency Medicine, becoming professor of Clinical Medicine and Emergency Medicine. She served as medical and executive...
Discussing CMS changes
Jan. 27, 2022—Former Centers for Medicare and Medicaid Services administrator Seema Verma, MPH, was recently the guest of Vanderbilt University Medical Center's Department of Health Policy’s Research into Policy and Practice Lecture Series.
Team seeks to rehab damaged donor livers for transplant
Jan. 26, 2022—A Vanderbilt team is studying whether injured human donor livers declined for transplant can be recovered by cross-circulation between the human liver and a xenogeneic host.
